InvestorsObserver
×
News Home

Is it Time to Dump Eliem Therapeutics Inc (ELYM) Stock After it Has Fallen 4.24% in a Week?

Friday, July 21, 2023 11:02 AM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump Eliem Therapeutics Inc (ELYM) Stock After it Has Fallen 4.24% in a Week?

The market has been high on Eliem Therapeutics Inc (ELYM) stock recently. ELYM gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Eliem Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ELYM!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ELYM Stock Today?

Eliem Therapeutics Inc (ELYM) stock has fallen -9.06% while the S&P 500 is higher by 0.21% as of 11:01 AM on Friday, Jul 21. ELYM is lower by -$0.27 from the previous closing price of $2.98 on volume of 48,029 shares. Over the past year the S&P 500 has gained 14.77% while ELYM is lower by -27.73%. ELYM lost -$2.06 per share in the over the last 12 months.

More About Eliem Therapeutics Inc

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Click Here to get the full Stock Report for Eliem Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App